Inventor · Stamford, CT, US

Mark Reynolds

32Patents
16h-index
44Co-inventors
81Inventor score

Filing activity: Jan 14, 1994 → Jan 21, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US5585481A Linking reagents for nucleotide probes Chemistry; Metallurgy 344 Expired
US5599667A Polycationic supports and nucleic acid purification separation and hybridization Chemistry; Metallurgy 145 Expired
US6673611B2 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression Chemistry; Metallurgy 103 Expired
US6060456A Chimeric oligonucleoside compounds Human Necessities 101 Expired
US5696251A Non-nucleotide linking reagents for nucleotide probes Chemistry; Metallurgy 76 Expired
US6395713B1 Compositions for the delivery of negatively charged molecules Chemistry; Metallurgy 74 Expired
US6031091A Non-nucleotide linking reagents for nucleotide probes Chemistry; Metallurgy 45 Expired
US5986083A Synthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphonate internucleosidyl linkages Chemistry; Metallurgy 42 Expired
US5656744A Methods for making nucleotide polymers using novel linking reagents Chemistry; Metallurgy 38 Expired
US8399222B2 Compositions and methods for detecting small RNAs, and uses thereof Chemistry; Metallurgy 26 Active
US6028188A Synthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages Human Necessities 25 Expired
US6262036A Method for inhibiting RNA translation using chimeric oligonucleoside compounds Human Necessities 24 Expired
US5854410A Oligonucleoside cleavage compounds and therapies Chemistry; Metallurgy 20 Expired
US6380169B1 Metal complex containing oligonucleoside cleavage compounds and therapies Chemistry; Metallurgy 18 Expired
US7553830B2 Compositions for the delivery of negatively charged molecules Chemistry; Metallurgy 18 Active
US6316608A Combined polynucleotide sequence as discrete assay endpoints Chemistry; Metallurgy 16 Expired
US10137127B2 Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide Human Necessities 16 Active
US5792615A Synthetic oligomers having chirally pure phoshonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages Human Necessities 12 Expired
US5837856A Chirally enriched synthetic phosphonate oligomers Chemistry; Metallurgy 11 Expired
US5955597A Chirally enriched synthetic phosphate oligomers Chemistry; Metallurgy 11 Expired
US9267305B1 Louvered snow plow Fixed Constructions 6 Active
US9938590B2 Capture probes immobilizable via L-nucleotide tail Emerging Cross-Sectional Technologies 4 Active
US5811538A Process for the purification of oligomers Performing Operations; Transporting 3 Expired
US10786489B2 Formulations of 6-(2-hydroxy-2-methylpropxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-A]pyridine-3-carbonitrile Human Necessities 3 Active
US10668072B2 Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide Human Necessities 2 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.